Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 48 | 2023 | 1402 | 6.150 |
Why?
|
| Staphylococcal Infections | 32 | 2023 | 1373 | 3.930 |
Why?
|
| Bacterial Capsules | 19 | 2019 | 265 | 3.760 |
Why?
|
| Staphylococcal Vaccines | 11 | 2021 | 30 | 3.720 |
Why?
|
| Polysaccharides, Bacterial | 14 | 2019 | 594 | 2.460 |
Why?
|
| Antibodies, Bacterial | 10 | 2021 | 1457 | 1.170 |
Why?
|
| Bacterial Toxins | 4 | 2021 | 958 | 1.040 |
Why?
|
| Coagulase | 3 | 2016 | 56 | 1.000 |
Why?
|
| Staphylococcal Skin Infections | 6 | 2021 | 76 | 0.960 |
Why?
|
| Bacterial Proteins | 16 | 2019 | 3948 | 0.850 |
Why?
|
| Antigens, Bacterial | 6 | 2016 | 1190 | 0.750 |
Why?
|
| Virulence Factors | 4 | 2021 | 523 | 0.740 |
Why?
|
| Cytotoxins | 1 | 2018 | 154 | 0.640 |
Why?
|
| Bacterial Vaccines | 3 | 2016 | 419 | 0.620 |
Why?
|
| Bacteremia | 7 | 2017 | 969 | 0.600 |
Why?
|
| Hemolysin Proteins | 1 | 2016 | 114 | 0.600 |
Why?
|
| Cell Wall | 4 | 2018 | 448 | 0.580 |
Why?
|
| Abscess | 5 | 2016 | 596 | 0.570 |
Why?
|
| Immunization, Passive | 5 | 2016 | 630 | 0.550 |
Why?
|
| Inflammasomes | 1 | 2020 | 444 | 0.540 |
Why?
|
| Teichoic Acids | 2 | 2015 | 66 | 0.530 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 159 | 0.530 |
Why?
|
| Wound Infection | 1 | 2016 | 241 | 0.520 |
Why?
|
| Anti-Bacterial Agents | 11 | 2021 | 7095 | 0.500 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 1498 | 0.480 |
Why?
|
| Cross Reactions | 1 | 2014 | 878 | 0.450 |
Why?
|
| Neutrophils | 7 | 2021 | 3800 | 0.440 |
Why?
|
| Bacterial Adhesion | 3 | 2015 | 325 | 0.430 |
Why?
|
| Staphylococcus haemolyticus | 2 | 2007 | 6 | 0.420 |
Why?
|
| Polysaccharides | 2 | 2019 | 995 | 0.410 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2022 | 666 | 0.410 |
Why?
|
| Staphylococcus | 1 | 2010 | 144 | 0.380 |
Why?
|
| Macrophages | 3 | 2021 | 5742 | 0.370 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 1836 | 0.360 |
Why?
|
| Fibrinogen | 2 | 2016 | 919 | 0.360 |
Why?
|
| Chemokines, CXC | 2 | 2008 | 442 | 0.330 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2013 | 4379 | 0.320 |
Why?
|
| Bacterial Load | 3 | 2017 | 158 | 0.320 |
Why?
|
| Sepsis | 2 | 2018 | 2465 | 0.310 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 1156 | 0.310 |
Why?
|
| Mice | 25 | 2020 | 80373 | 0.310 |
Why?
|
| Virulence | 7 | 2021 | 1338 | 0.290 |
Why?
|
| Vaccines, Subunit | 2 | 2016 | 142 | 0.290 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 123 | 0.280 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 2 | 2016 | 49 | 0.280 |
Why?
|
| Glycoproteins | 1 | 2013 | 2306 | 0.270 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 18197 | 0.270 |
Why?
|
| Opsonin Proteins | 3 | 2016 | 154 | 0.270 |
Why?
|
| Animals | 34 | 2021 | 169404 | 0.260 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2019 | 1154 | 0.250 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1397 | 0.250 |
Why?
|
| Vaccines, Synthetic | 3 | 2016 | 634 | 0.250 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 664 | 0.250 |
Why?
|
| Phagocytosis | 3 | 2016 | 1581 | 0.240 |
Why?
|
| Nasal Mucosa | 1 | 2006 | 370 | 0.230 |
Why?
|
| Membrane Proteins | 2 | 2023 | 8047 | 0.230 |
Why?
|
| Rabbits | 5 | 2021 | 5060 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 1205 | 0.220 |
Why?
|
| Diabetic Foot | 1 | 2005 | 342 | 0.210 |
Why?
|
| Skin Diseases | 1 | 2010 | 1066 | 0.210 |
Why?
|
| Escherichia coli | 1 | 2013 | 4277 | 0.210 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 1489 | 0.210 |
Why?
|
| Vaccines, Conjugate | 4 | 2017 | 328 | 0.200 |
Why?
|
| Erythromycin | 1 | 2021 | 121 | 0.200 |
Why?
|
| Blood Bactericidal Activity | 2 | 2014 | 129 | 0.200 |
Why?
|
| Osmotic Pressure | 1 | 2021 | 156 | 0.200 |
Why?
|
| Mastitis | 3 | 2016 | 42 | 0.200 |
Why?
|
| Mice, Inbred ICR | 2 | 2014 | 372 | 0.190 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 78 | 0.190 |
Why?
|
| HL-60 Cells | 1 | 2021 | 369 | 0.190 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 134 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4454 | 0.180 |
Why?
|
| Carbohydrate Sequence | 2 | 2010 | 417 | 0.180 |
Why?
|
| Peptidoglycan | 2 | 2018 | 282 | 0.170 |
Why?
|
| Immunity, Innate | 2 | 2016 | 2943 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 6641 | 0.160 |
Why?
|
| Cystic Fibrosis | 2 | 2016 | 1133 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2007 | 2474 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2018 | 10503 | 0.150 |
Why?
|
| Cell Survival | 2 | 2021 | 6035 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 3 | 2017 | 975 | 0.140 |
Why?
|
| Pneumonia, Staphylococcal | 2 | 2013 | 45 | 0.140 |
Why?
|
| Multigene Family | 3 | 2019 | 1122 | 0.140 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 94 | 0.140 |
Why?
|
| Microvilli | 1 | 2016 | 249 | 0.140 |
Why?
|
| Endocytosis | 1 | 2020 | 1006 | 0.140 |
Why?
|
| Cross Protection | 1 | 2014 | 25 | 0.130 |
Why?
|
| Apoptosis | 1 | 2011 | 9971 | 0.130 |
Why?
|
| Drug Compounding | 1 | 2016 | 243 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 249 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2020 | 914 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2021 | 1920 | 0.130 |
Why?
|
| Hydro-Lyases | 1 | 2014 | 96 | 0.130 |
Why?
|
| Temperature | 1 | 2021 | 2143 | 0.130 |
Why?
|
| Biofilms | 3 | 2022 | 628 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 22663 | 0.120 |
Why?
|
| Hindlimb | 2 | 2006 | 546 | 0.120 |
Why?
|
| Glycerophosphates | 1 | 2013 | 47 | 0.120 |
Why?
|
| Glycoconjugates | 1 | 2013 | 89 | 0.120 |
Why?
|
| Osteomyelitis | 2 | 2016 | 389 | 0.120 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 142 | 0.120 |
Why?
|
| Biological Therapy | 1 | 2015 | 144 | 0.120 |
Why?
|
| Microbial Viability | 1 | 2014 | 230 | 0.120 |
Why?
|
| Carrier State | 2 | 2016 | 538 | 0.120 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 143 | 0.110 |
Why?
|
| Leukocidins | 2 | 2008 | 17 | 0.110 |
Why?
|
| Bacteriophages | 1 | 2015 | 349 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2018 | 944 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2014 | 1268 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 18591 | 0.110 |
Why?
|
| Exotoxins | 2 | 2008 | 121 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2020 | 19905 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2015 | 779 | 0.100 |
Why?
|
| Placebos | 1 | 2016 | 1735 | 0.100 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 2033 | 0.100 |
Why?
|
| Vaccination | 2 | 2018 | 2938 | 0.100 |
Why?
|
| Genes, Bacterial | 3 | 2006 | 1136 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1402 | 0.100 |
Why?
|
| Proteomics | 1 | 2023 | 3248 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 249 | 0.090 |
Why?
|
| Vancomycin | 1 | 2013 | 507 | 0.090 |
Why?
|
| Gentamicins | 1 | 2010 | 260 | 0.090 |
Why?
|
| Electrolytes | 1 | 2010 | 277 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3129 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3687 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3636 | 0.090 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 337 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2649 | 0.080 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 202 | 0.080 |
Why?
|
| Humans | 24 | 2023 | 715818 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2008 | 342 | 0.080 |
Why?
|
| Genetic Complementation Test | 3 | 2015 | 585 | 0.080 |
Why?
|
| Operon | 2 | 2019 | 374 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4492 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3844 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2013 | 1977 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 1020 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 3 | 2016 | 9549 | 0.070 |
Why?
|
| Female | 15 | 2021 | 377229 | 0.070 |
Why?
|
| Cattle | 3 | 2008 | 3958 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 782 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2015 | 791 | 0.070 |
Why?
|
| Vaccines, Inactivated | 1 | 2006 | 182 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 11090 | 0.070 |
Why?
|
| Respiratory Burst | 1 | 2005 | 130 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1935 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 6009 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 474 | 0.070 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 384 | 0.070 |
Why?
|
| Serotyping | 1 | 2005 | 377 | 0.070 |
Why?
|
| Administration, Intranasal | 1 | 2006 | 458 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 3034 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 528 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8542 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 275 | 0.060 |
Why?
|
| Uridine Diphosphate Sugars | 1 | 2002 | 11 | 0.060 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 2002 | 17 | 0.060 |
Why?
|
| Complement C3 | 1 | 2005 | 466 | 0.060 |
Why?
|
| Family Health | 1 | 2008 | 1289 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2007 | 1951 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3897 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2022 | 255 | 0.060 |
Why?
|
| Vitamin K 3 | 1 | 2021 | 13 | 0.060 |
Why?
|
| O Antigens | 1 | 2002 | 172 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1726 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 1904 | 0.050 |
Why?
|
| Base Sequence | 3 | 2012 | 13179 | 0.050 |
Why?
|
| Rats | 4 | 2016 | 24852 | 0.050 |
Why?
|
| Urea | 1 | 2022 | 441 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 1534 | 0.050 |
Why?
|
| Antibodies | 1 | 2008 | 2432 | 0.050 |
Why?
|
| Nose | 2 | 2015 | 494 | 0.050 |
Why?
|
| Point Mutation | 1 | 2006 | 1651 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 7885 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4918 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3250 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 1739 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1780 | 0.040 |
Why?
|
| Sigma Factor | 1 | 2019 | 173 | 0.040 |
Why?
|
| RNA, Bacterial | 2 | 2015 | 395 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16311 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2015 | 1238 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2022 | 1155 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2005 | 1356 | 0.040 |
Why?
|
| Complement C3b | 1 | 2016 | 107 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2007 | 6093 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23729 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 1277 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2019 | 3063 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 2 | 2008 | 303 | 0.040 |
Why?
|
| Cell Line | 1 | 2010 | 16575 | 0.040 |
Why?
|
| Mutation | 3 | 2016 | 29290 | 0.030 |
Why?
|
| Suramin | 1 | 2014 | 35 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 197 | 0.030 |
Why?
|
| Ampicillin | 1 | 2014 | 145 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10615 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2015 | 141 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 684 | 0.030 |
Why?
|
| DNA Primers | 2 | 2012 | 2979 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 36 | 0.030 |
Why?
|
| Cell Movement | 1 | 2006 | 5397 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 371 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 459 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2013 | 119 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1997 | 920 | 0.030 |
Why?
|
| Immune Sera | 1 | 2013 | 705 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 2013 | 208 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 7960 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 529 | 0.030 |
Why?
|
| Male | 8 | 2021 | 350352 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 731 | 0.030 |
Why?
|
| Kinetics | 2 | 2014 | 6654 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 3047 | 0.030 |
Why?
|
| Culture Media | 1 | 2012 | 945 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6213 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 267 | 0.020 |
Why?
|
| Bronchi | 1 | 2013 | 841 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2010 | 201 | 0.020 |
Why?
|
| Methicillin | 1 | 2008 | 59 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2167 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1974 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1684 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2016 | 1425 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9558 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2459 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1334 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1938 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1606 | 0.020 |
Why?
|
| Synteny | 1 | 2005 | 86 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 400 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2005 | 205 | 0.020 |
Why?
|
| Gene Order | 1 | 2005 | 183 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2005 | 116 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3947 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6803 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2824 | 0.020 |
Why?
|
| Iron | 1 | 2012 | 1735 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 1531 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 4312 | 0.010 |
Why?
|
| Electrophoresis, Capillary | 1 | 2002 | 75 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 11940 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2005 | 757 | 0.010 |
Why?
|
| Cross Infection | 1 | 2010 | 1407 | 0.010 |
Why?
|
| Catalysis | 1 | 2002 | 777 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4893 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 1202 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 513 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2005 | 1084 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7954 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 11953 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 62040 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12919 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 1106 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13643 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5853 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 257 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 2222 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9739 | 0.010 |
Why?
|
| Child | 2 | 2013 | 74468 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 15058 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2121 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2284 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16735 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 9034 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 56228 | 0.000 |
Why?
|
| Adult | 2 | 2013 | 212279 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2002 | 13212 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 41198 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2013 | 72473 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 85157 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 14161 | 0.000 |
Why?
|
Concepts
(271)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_